Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2020
  2. Published

    Physical deterioration and adaptive recovery in physically inactive breast cancer patients during adjuvant chemotherapy: a randomised controlled trial

    Møller, T., Andersen, C., Lillelund, C., Bloomquist, K., Christensen, K. B., Ejlertsen, B., Tuxen, M., Oturai, P., Breitenstein, U., Kolind, C., Travis, P., Bjerg, T., Rørth, M. & Adamsen, L., 16 Jun 2020, In : Scientific Reports. 10, 1, p. 9710

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2019
  4. Published

    Heavy-load resistance exercise during chemotherapy in physically inactive breast cancer survivors at risk for lymphedema: a randomized trial

    Bloomquist, K., Adamsen, L., Hayes, S. C., Lillelund, C., Andersen, C., Christensen, K. B., Oturai, P., Ejlertsen, B., Tuxen, M. K. & Møller, T., Dec 2019, In : Acta oncologica . 58, 12, p. 1667-1675 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2018
  6. Published

    Are previous episodes of bacterial vaginosis a predictor for vaginal symptoms in breast cancer patients treated with aromatase inhibitors?

    Gade, M. R., Goukasian, I., Panduro, N., Kamby, C., Nilas, L., Tuxen, M. K. & Bjerrum, L., Jun 2018, In : Post reproductive health. 24, 2, p. 67-71

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)

    Lindman, H., Andersson, M., Ahlgren, J., Balslev, E., Sverrisdottir, A., Holmberg, S. B., Bengtsson, N. O., Jacobsen, E. H., Jensen, A. B., Hansen, J., Tuxen, M. K., Malmberg, L., Villman, K., Anderson, H., Ejlertsen, B., Bergh, J., Blomqvist, C. & Swedish Breast Cancer Group (SweBCG), the Danish Breast Cancer Group (DBCG) and the Scandinavian Breast Cancer Group (SBG), May 2018, In : European journal of cancer (Oxford, England : 1990). 94, p. 79-86 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Is DBCG abreast of new developments?

    Offersen, B. V., Ejlertsen, B., Balslev, E., Flyger, H., Gerdes, A-M., Hansen, M. K., Hølmich, L. R., Jensen, M-B., Kristensen, B., Laenkholm, A-V., Mouridsen, H. T., Nielsen, M. H., Overgaard, J., Tuxen, M., Vejborg, I. & Christiansen, P., Jan 2018, In : Acta oncologica . 57, 1, p. 1-2 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2017
  10. Published

    Adjuvant Cyclophosphamide and Docetaxel With or Without Epirubicin for Early TOP2A-Normal Breast Cancer: DBCG 07-READ, an Open-Label, Phase III, Randomized Trial

    Ejlertsen, B., Tuxen, M. K., Jakobsen, E. H., Jensen, M-B., Knoop, A. S., Højris, I., Ewertz, M., Balslev, E., Danø, H., Vestlev, P. M., Kenholm, J., Nielsen, D. L., Bechmann, T., Andersson, M., Cold, S., Nielsen, H. M., Maae, E., Carlsen, D. & Mouridsen, H. T., Aug 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 23, p. 2639-2646

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published
  12. 2016
  13. Published

    Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers

    Söletormos, G., Duffy, M. J., Othman Abu Hassan, S., Verheijen, R. H. M., Tholander, B., Bast, R. C., Gaarenstroom, K. N., Sturgeon, C. M., Bonfrer, J. M., Petersen, P. H., Troonen, H., CarloTorre, G., Kanty Kulpa, J., Tuxen, M. K. & Molina, R., 2016, In : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 26, 1, p. 43-51

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. 2015
  15. Published
  16. Published

    Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer

    Kümler, I., Kirk Parner, V., Tuxen, M. K., Skjoldbye, B., Bergenfeldt, M., Nelausen, K. M. & Nielsen, D. L., Jun 2015, In : La Radiologia Medica. 120, 6, p. 536-41 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published
  18. 2014
  19. Published

    Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer

    Tuxen, M. K., Cold, S., Tange, U. B., Balslev, E. & Nielsen, D. L., Oct 2014, In : Acta oncologica . 53, 10, p. 1440-5 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    A systematic review of dual targeting in HER2-positive breast cancer

    Kümler, I., Tuxen, M. K. & Nielsen, D. L., Mar 2014, In : Cancer Treatment Reviews. 40, 2, p. 259-70 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Clinicopathological evaluation and outcome of young breast cancer pationts developing brain metastasis in single institution cohort.

    Tuxen, M., 2014.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  22. 2013
  23. Published

    Behandling af patienter med primær lokoregional avanceret cancer mammae - et dansk forsøg

    Tuxen, M., 2013, In : Best Practice. p. 10-13 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Design of Tumor Biomarker-Monitoring Trials: A Proposal by the European Group on Tumor Markers

    Söletormos, G., Duffy, M. J., Hayes, D. F., Sturgeon, C. M., Barak, V., Bossuyt, P. M., Diamandis, E. P., Gion, M., Hyltoft-Petersen, P., Lamerz, R. M., Nielsen, D. L., Sibley, P., Tholander, B., Tuxen, M. K. & Bonfrer, J. M. G., 2013, In : Clinical Chemistry (Washington, DC). 59, 1, p. 52-9

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. 2011
  26. Published

    Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

    Bernsdorf, M., Ingvar, C., Jörgensen, L., Tuxen, M. K., Jakobsen, P. E., Saetersdal, A., Kimper-Karl, M. L., Kroman, N., Balslev, E. & Ejlertsen, B., 2011, In : Breast Cancer Research and Treatment. 126, 2, p. 463-70 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. 2001
  28. Published

    Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy

    Tuxen, M. K., Sölétormos, G. & Dombernowsky, P., 18 May 2001, In : B J C. 84, 10, p. 1301-7 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. 2000
  30. Published

    Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer

    Tuxen, M. K., Sölétormos, G., Rustin, G. J., Nelstrop, A. E. & Dombernowsky, P., Dec 2000, In : Scandinavian Journal of Clinical and Laboratory Investigation. 60, 8, p. 713-21 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. 1999
  32. Published

    Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer

    Tuxen, M. K., Sölétormos, G., Petersen, P. H., Schioler, V. & Dombernowsky, P., Jul 1999, In : Gynecologic Oncology. 74, 1, p. 12-22 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. 1995
  34. Published

    Tumor markers in the management of patients with ovarian cancer

    Tuxen, M. K., Sölétormos, G. & Dombernowsky, P., May 1995, In : Evidence-based Oncology. 21, 3, p. 215-45 31 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 9760